Neurocrine Biosciences
NBIX
#1304
Rank
NZ$31.54 B
Marketcap
NZ$311.61
Share price
2.58%
Change (1 day)
17.23%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company